These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 8786722

  • 1. Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.
    Velthuis-te Wierik EJ, Meijer P, Kluft C, van den Berg H.
    Metabolism; 1995 Dec; 44(12):1548-52. PubMed ID: 8786722
    [Abstract] [Full Text] [Related]

  • 2. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB.
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [Abstract] [Full Text] [Related]

  • 3. Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction.
    Calles-Escandon J, Ballor D, Harvey-Berino J, Ades P, Tracy R, Sobel B.
    Am J Clin Nutr; 1996 Jul; 64(1):7-11. PubMed ID: 8669417
    [Abstract] [Full Text] [Related]

  • 4. The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents.
    Sudi KM, Gallistl S, Tröbinger M, Payerl D, Weinhandl G, Muntean W, Aigner R, Borkenstein MH.
    J Pediatr Endocrinol Metab; 2001 Jan; 14(1):85-94. PubMed ID: 11220710
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of body build, diet and endocrine factors on the extrinsic fibrinolytic system in healthy young women.
    Sundell IB, Nilsson TK, Hallmans G, Nygren C.
    Scand J Clin Lab Invest; 1988 Oct; 48(6):557-64. PubMed ID: 3146134
    [Abstract] [Full Text] [Related]

  • 9. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance.
    Hadigan C, Meigs JB, Rabe J, D'Agostino RB, Wilson PW, Lipinska I, Tofler GH, Grinspoon SS, Framingham Heart Study.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):939-43. PubMed ID: 11158071
    [Abstract] [Full Text] [Related]

  • 10. Fibrinolytic activity is similar in physically active men with and without a history of myocardial infarction.
    Fernhall B, Szymanski LM, Gorman PA, Milani J, Paup DC, Kessler CM.
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1106-13. PubMed ID: 9194761
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
    Akanji AO, Abdullah A, Tahzeeb S.
    Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
    [Abstract] [Full Text] [Related]

  • 12. Impaired fibrinolysis and insulin resistance in patients with hypertension.
    Jeng JR, Sheu WH, Jeng CY, Huang SH, Shieh SM.
    Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
    [Abstract] [Full Text] [Related]

  • 13. Endurance physical activity, diet and fibrinolysis.
    Boman K, Hellsten G, Bruce A, Hallmans G, Nilsson TK.
    Atherosclerosis; 1994 Mar; 106(1):65-74. PubMed ID: 8018108
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, Hallmans G.
    Circulation; 1998 Nov 24; 98(21):2241-7. PubMed ID: 9826309
    [Abstract] [Full Text] [Related]

  • 16. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A, Bayraktar M, Kirazli S.
    Diabetes Care; 2000 Jan 24; 23(1):88-92. PubMed ID: 10857975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Progressive intermittent claudication is associated with impaired fibrinolysis.
    Killewich LA, Gardner AW, Macko RF, Hanna DJ, Goldberg AP, Cox DK, Flinn WR.
    J Vasc Surg; 1998 Apr 24; 27(4):645-50. PubMed ID: 9576077
    [Abstract] [Full Text] [Related]

  • 19. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.
    Ruiz-Argüelles GJ, Ruiz-Argüelles A, Lobato-Mendizábal E, Díaz-Gomez F, Pacheco-Pantoja E, Drenkard C, Alarcón-Segovia D.
    Am J Hematol; 1991 May 24; 37(1):9-13. PubMed ID: 1902623
    [Abstract] [Full Text] [Related]

  • 20. Normal plasminogen activator inhibitor levels at long-term follow-up after jejuno-ileal bypass surgery in morbidly obese individuals.
    Sylvan A, Rutegård JN, Janunger KG, Sjölund B, Nilsson TK.
    Metabolism; 1992 Dec 24; 41(12):1370-2. PubMed ID: 1461144
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.